MINJI KIM: Open Payments
NPI 1720424591 · MEDFORD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$18,045 in 35 payments from 9 companies in 2025. Trend: 2023 $1,068 · 2024 $6,070 · 2025 $18,045
Consulting: $11,100Travel & lodging: $4,579Food & beverage: $1,678Speaker / faculty: $688
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 15 | $9,940 |
| ARGENX US, INC. | 10 | $7,411 |
| AstraZeneca Pharmaceuticals LP | 3 | $251 |
| Becton, Dickinson and Company | 1 | $200 |
| Genentech USA, Inc. | 1 | $99 |
| Cadwell Industries, INC | 1 | $70 |
| ABBVIE INC. | 2 | $28 |
| UCB, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
Products named: VYVGART HYTRULO, UPLIZNA, Phasix Mesh, WAINUA, Ocrevus, QULIPTA, Rystiggo, HYQVIA.
Industry payments across OR — which companies pay providers there.
